Logo image of IVP

INSPIRE VETERINARY PARTNE-A (IVP) Stock Fundamental Analysis

NASDAQ:IVP - Nasdaq - US45784E3045 - Common Stock - Currency: USD

1.93  +0.11 (+6.04%)

After market: 1.95 +0.02 (+1.04%)

Fundamental Rating

1

Overall IVP gets a fundamental rating of 1 out of 10. We evaluated IVP against 102 industry peers in the Health Care Providers & Services industry. IVP may be in some trouble as it scores bad on both profitability and health. IVP has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year IVP has reported negative net income.
In the past year IVP has reported a negative cash flow from operations.
IVP had negative earnings in each of the past 5 years.
In the past 5 years IVP always reported negative operating cash flow.
IVP Yearly Net Income VS EBIT VS OCF VS FCFIVP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

IVP has a worse Return On Assets (-64.20%) than 92.16% of its industry peers.
IVP has a Return On Equity of -441.54%. This is amonst the worse of the industry: IVP underperforms 82.35% of its industry peers.
Industry RankSector Rank
ROA -64.2%
ROE -441.54%
ROIC N/A
ROA(3y)-55.06%
ROA(5y)-37.24%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IVP Yearly ROA, ROE, ROICIVP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 500 -500 1K 1.5K

1.3 Margins

IVP's Gross Margin of 18.84% is on the low side compared to the rest of the industry. IVP is outperformed by 60.78% of its industry peers.
In the last couple of years the Gross Margin of IVP has declined.
The Profit Margin and Operating Margin are not available for IVP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.84%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.18%
GM growth 5YN/A
IVP Yearly Profit, Operating, Gross MarginsIVP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

More info and screens

0

2. Health

2.1 Basic Checks

IVP does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for IVP has been increased compared to 1 year ago.
IVP has a better debt/assets ratio than last year.
IVP Yearly Shares OutstandingIVP Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 1M 2M 3M 4M
IVP Yearly Total Debt VS Total AssetsIVP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

IVP has an Altman-Z score of -3.32. This is a bad value and indicates that IVP is not financially healthy and even has some risk of bankruptcy.
IVP has a Altman-Z score of -3.32. This is amonst the worse of the industry: IVP underperforms 87.25% of its industry peers.
A Debt/Equity ratio of 3.34 is on the high side and indicates that IVP has dependencies on debt financing.
The Debt to Equity ratio of IVP (3.34) is worse than 80.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.34
Debt/FCF N/A
Altman-Z -3.32
ROIC/WACCN/A
WACC9.81%
IVP Yearly LT Debt VS Equity VS FCFIVP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M -5M 10M -10M 15M

2.3 Liquidity

A Current Ratio of 0.39 indicates that IVP may have some problems paying its short term obligations.
IVP has a Current ratio of 0.39. This is amonst the worse of the industry: IVP underperforms 91.18% of its industry peers.
IVP has a Quick Ratio of 0.39. This is a bad value and indicates that IVP is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.32, IVP is doing worse than 92.16% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.39
Quick Ratio 0.32
IVP Yearly Current Assets VS Current LiabilitesIVP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 98.91% over the past year.
IVP shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.59%.
IVP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 86.71% yearly.
EPS 1Y (TTM)98.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.81%
Revenue 1Y (TTM)-10.59%
Revenue growth 3Y86.71%
Revenue growth 5YN/A
Sales Q2Q%-24.68%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IVP Yearly Revenue VS EstimatesIVP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 5M 10M 15M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

IVP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IVP Price Earnings VS Forward Price EarningsIVP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IVP Per share dataIVP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30 -40 -50

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for IVP!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INSPIRE VETERINARY PARTNE-A

NASDAQ:IVP (6/12/2025, 8:00:11 PM)

After market: 1.95 +0.02 (+1.04%)

1.93

+0.11 (+6.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.94%
Inst Owner Change-65.46%
Ins Owners0%
Ins Owner Change0%
Market Cap9.92M
AnalystsN/A
Price TargetN/A
Short Float %5.02%
Short Ratio1.93
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.64
P/FCF N/A
P/OCF N/A
P/B 3.3
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-51.57
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.62
FCFYN/A
OCF(TTM)-1.6
OCFYN/A
SpS3
BVpS0.58
TBVpS-1.26
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -64.2%
ROE -441.54%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.84%
FCFM N/A
ROA(3y)-55.06%
ROA(5y)-37.24%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.18%
GM growth 5YN/A
F-Score5
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 3.34
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 6.05%
Cap/Sales 0.66%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.39
Quick Ratio 0.32
Altman-Z -3.32
F-Score5
WACC9.81%
ROIC/WACCN/A
Cap/Depr(3y)24.86%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.84%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.81%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-10.59%
Revenue growth 3Y86.71%
Revenue growth 5YN/A
Sales Q2Q%-24.68%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-12.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-256.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-283.75%
OCF growth 3YN/A
OCF growth 5YN/A